Skip to main content
SpringerLink
Log in

Breast Cancer Progression: A “Vicious Cycle” of Pro-Malignancy Activities is Mediated by Inflammatory Cells, Chemokines and Cytokines

  • Chapter
Integration/Interaction of Oncologic Growth

Part of the book series: Cancer Growth and Progression ((CAGP,volume 15))

Abstract

Breast cancer progression is a multi-step process, affected by intrinsic, as well as by microenvironmental factors. The inflammatory milieu of breast tumors, comprising of cells, chemokines and cytokines, was recently suggested to have a major role in this process. The current chapter addresses the presence of these elements in breast tumors, and their roles in the malignancy and metastatic fate of breast cancer. First, the presence of Tumor-Associated Macrophages (TAM), and the array of tumor-promoting activities that they exert in breast tumors, is described. Thereafter, the inflammatory chemokines CCL2 (MCP-1), CCL5 (RANTES) and CXCL8 (Interleukin 8) are addressed, followed by description of the expression and roles of inflammatory cytokines, which are monocyte/macrophage-derived, namely Interleukin 1 (IL-1), Tumor Necrosis Factor α (TNFα) and Interleukin 6 (IL-6). Throughout the chapter, major emphasis is put on the manner by which the different inflammatory mediators cross-interact with each other, as well as with the tumor cells, together establishing an inflammatory microenvironment that consists of an extensive network of pro-malignancy activities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Roskelley, C. D., and Bissell, M. J., 2002, The dominance of the microenvironment in breast and ovarian cancer. Semin Cancer Biol, 12:97.

    Article  PubMed  Google Scholar 

  2. Liotta, L. A., and Kohn, E. C., 2001, The microenvironment of the tumour-host interface. Nature, 411:375.

    Article  PubMed  Google Scholar 

  3. Witz, I. P., 2001, Presence and functions of immune components in the tumor microenvironment. Adv Exp Med Biol, 495:317.

    PubMed  Google Scholar 

  4. DeClerck, Y. A., 2000, Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer. Eur J Cancer, 36:1258.

    Article  PubMed  Google Scholar 

  5. Yu, J. L., and Rak, J. W., 2003, Host microenvironment in breast cancer development: inflammatory and immune cells in tumour angiogenesis and arteriogenesis. Breast Cancer Res, 5:83.

    Article  PubMed  Google Scholar 

  6. Coussens, L. M., and Werb, Z., 2001, Inflammatory cells and cancer: think different!. J Exp Med, 193:F23.

    Article  PubMed  Google Scholar 

  7. Brigati, C., Noonan, D. M., Albini, A., and Benelli, R., 2002, Tumors and inflammatory infiltrates: friends or foes?. Clin Exp Metastasis, 19:247.

    Article  PubMed  Google Scholar 

  8. Coussens, L. M., and Werb, Z., 2002, Inflammation and cancer. Nature, 420:860.

    Article  PubMed  Google Scholar 

  9. Sica, A., Saccani, A., and Mantovani, A., 2002, Tumor-associated macrophages: a molecular perspective. Int Immunopharmacol, 2:1045.

    Article  PubMed  Google Scholar 

  10. Balkwill, F., and Mantovani, A., 2001, Inflammation and cancer: back to Virchow?. Lancet 357:539.

    Article  Google Scholar 

  11. Leek, R. D., and Harris, A. L., 2002, Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia, 7:177.

    Article  PubMed  Google Scholar 

  12. Ben-Baruch, A., 2002, Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Res, 5:31.

    Article  PubMed  Google Scholar 

  13. Bingle, L., Brown, N. J., and Lewis, C. E., 2002, The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol, 196:254.

    Article  PubMed  Google Scholar 

  14. Kurebayashi, J., 2000, Regulation of interleukin-6 secretion from breast cancer cells and its clinical implications. Breast Cancer, 7:124.

    PubMed  Google Scholar 

  15. Wilson, J., and Balkwill, F., 2002, The role of cytokines in the epithelial cancer microenvironment. Semin Cancer Biol, 12:113.

    Article  PubMed  Google Scholar 

  16. Balkwill, F., 2002, Tumor necrosis factor or tumor promoting factor?. Cytokine Growth Factor Rev, 13:135.

    PubMed  Google Scholar 

  17. Wang, J. M., Deng, X., Gong, W., and Su, S., 1998, Chemokines and their role in tumor growth and metastasis. J Immunol Methods, 220:1.

    Article  PubMed  Google Scholar 

  18. Vicari, A. P., and Caux. C., 2002, Chemokines in cancer. Cytokine Growth Factor Rev, 13:143.

    Article  PubMed  Google Scholar 

  19. van Ravenswaay Claasen, H. H., Kluin, P. M., and Fleuren. G. J., 1992, Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity. Lab Invest, 67:166.

    PubMed  Google Scholar 

  20. Tang, R., Beuvon, F., Ojeda, M., Mosseri, V., Pouillart, P., and Scholl S., 1992, M-CSF (monocyte colony stimulating factor) and M-CSF receptor expression by breast tumour cells: M-CSF mediated recruitment of tumour infiltrating monocytes?. J Cell Biochem, 50:350.

    Article  PubMed  Google Scholar 

  21. Pupa, S. M.., Bufalino, R., Invernizzi, A. M., Andreola, S., Rilke, F., Lombardi, L., Colnaghi, M. I., and Menard. S., 1996, Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas. J Clin Oncol, 14:85.

    PubMed  Google Scholar 

  22. Ben-Hur, H., Cohen, O., Schneider, D., Gurevich, P., Halperin, R., Bala, U., Mozes, M., and Zusman I., 2002, The role of lymphocytes and macrophages in human breast tumorigenesis: an immunohistochemical and morphometric study. Anticancer Res, 22:1231.

    PubMed  Google Scholar 

  23. An, T., Sood, U., Pietruk, T., Cummings, G., Hashimoto, K., and Crissman J. D., 1987, In situ quantitation of inflammatory mononuclear cells in ductal infiltrating breast carcinoma. Relation to prognostic parameters. Am J Pathol, 128:52.

    PubMed  Google Scholar 

  24. Lee, A. H., Happerfield, L. C., Millis, R. R., and Bobrow, L. G., 1996, Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast. Br J Cancer, 74:796.

    PubMed  Google Scholar 

  25. O'sullivan, C., and Lewis, C. E., 1994, Tumour-associated leucocytes: friends or foes in breast carcinoma. J Pathol, 172:229.

    Article  PubMed  Google Scholar 

  26. Stewart, T. H., and Heppner, G. H., 1997, Immunological enhancement of breast cancer. Parasitology, 115Suppl:S141.

    Article  PubMed  Google Scholar 

  27. Visscher, D. W., Tabaczka, P., Long, D., and Crissman, J. D., 1995, Clinicopathologic analysis of macrophage infiltrates in breast carcinoma. Pathol Res Pract, 191:1133.

    PubMed  Google Scholar 

  28. van Netten, J. P., Ashmed, B. J., Cavers, D., Fletcher, C., Thornton, I. G., Antonsen, B. L., Coy, P., and Brigden, M. L., 1992, 'Macrophages’ and their putative significance in human breast cancer. Br J Cancer, 66:220.

    PubMed  Google Scholar 

  29. Lee, A. H., Happerfield, L. C., Bobrow, L. G., and Millis, R. R., 1997, Angiogenesis and inflammation in invasive carcinoma of the breast. J Clin Pathol, 50:669.

    PubMed  Google Scholar 

  30. van Netten, J. P., Ashmead, B. J., Parker, R. L., Thornton, I. G., Fletcher, C., Cavers, D., Coy, P., and Brigden, M. L., 1993, Macrophage-tumor cell associations: a factor in metastasis of breast cancer? J Leukoc Biol, 54:360.

    PubMed  Google Scholar 

  31. Volodko, N., Reiner, A., Rudas, M., and Jakesz R.,. 2004, Tumour-associated macrophages in breast cancer and their prognostic correlations. The Breast, 7:99.

    Article  Google Scholar 

  32. Leek, R. D., Lewis, C. E., Whitehouse, R., Greenall, M., Clarke, J., and Harris A. L., 1996, Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res, 56:4625.

    PubMed  Google Scholar 

  33. Lee, A. H., Happerfield, L. C., Bobrow, L. G., and Millis, R. R., 1997, Angiogenesis and inflammation in ductal carcinoma in situ of the breast. J Pathol, 181:200.

    Article  PubMed  Google Scholar 

  34. Leek, R. D., Landers, R. J., Harris, A. L., and Lewis, C. E., 1999, Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer, 79:991.

    Article  PubMed  Google Scholar 

  35. Lewis, C. E., Leek, R., Harris, A., and McGee, J. O., 1995, Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leukoc Biol, 57:747.

    PubMed  Google Scholar 

  36. Goede, V., Brogelli, L., Ziche, M., and Augustin, H. G., 1999, Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer, 82:765.

    Article  PubMed  Google Scholar 

  37. Leek, R. D., Hunt, N. C., Landers, R. J., Lewis, C. E., Royds, J. A., and Harris, A. L., 2000, Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J Pathol, 190:430.

    Article  PubMed  Google Scholar 

  38. van Netten, J. P., George, E. J., Ashmead, B. J., Fletcher, C., Thornton, I. G., and Coy, P., 1993, Macrophage-tumour cell associations in breast cancer. Lancet, 342:872.

    Article  Google Scholar 

  39. Hadden, J. W., 1999, The immunology and immunotherapy of breast cancer: an update. Int J Immunopharmacol, 21:79.

    Article  PubMed  Google Scholar 

  40. Wei, W. Z., and Heppner, G. H., 1996, Breast cancer immunology. Cancer Treat Res, 83:395.

    PubMed  Google Scholar 

  41. Schirrmacher, V., Feuerer, M., Beckhove, P., Ahlert, T., and Umansky, V., 2002, T cell memory, anergy and immunotherapy in breast cancer. J Mammary Gland Biol Neoplasia, 7:201.

    Article  PubMed  Google Scholar 

  42. Jonjic, N., Valkovic, T., Lucin, K., Iternicka, Z., Krstulja, M., Mustac, E., Dobi-Babic, R., Sasso, F., and Melato, M., 1998, Comparison of microvessel density with tumor associated macrophages in invasive breast carcinoma. Anticancer Res, 18:3767.

    PubMed  Google Scholar 

  43. Toi, M., Ueno, T., Matsumoto, H., Saji, H., Funata, N., Koike, M., and Tominaga, T., 1999, Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer. Clin Cancer Res, 5:1131.

    PubMed  Google Scholar 

  44. Crowther, M., Brown, N. J., Bishop, E. T., and Lewis, C. E., 2001, Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol, 70:478.

    PubMed  Google Scholar 

  45. Mantovani, A., Ming, W. J., Balotta, C., Abdeljalil, B. and Bottazzi, B., 1986, Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factor. Biochim Biophys Acta, 865:59.

    PubMed  Google Scholar 

  46. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., and Sica, A., 2002, Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol, 23:549.

    PubMed  Google Scholar 

  47. Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., and Ruco, L., 1992, The origin and function of tumor-associated macrophages. Immunol Today, 13:265.

    Article  PubMed  Google Scholar 

  48. Lewis, J. S., Landers, R. J., Underwood, J. C., Harris, A. L., and Lewis, C. E., 2000, Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J Pathol, 192:150.

    Article  PubMed  Google Scholar 

  49. Barbera-Guillem, E., Nyhus, J. K., Wolford, C. C., Friece, C. R., and Sampsel, J. W., 2002, Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. Cancer Res, 62:7042.

    PubMed  Google Scholar 

  50. O'sullivan, C., Lewis, C. E., Harris, A. L, and McGee, J. O., 1993, Secretion of epidermal growth factor by macrophages associated with breast carcinoma. Lancet, 342:148.

    Article  PubMed  Google Scholar 

  51. Mor, G., Yue, W., Santen, R. J., Gutierrez, L., Eliza, M., Berstein, L. M., Harada, N., Wang, J., Lysiak, J., Diano, S., and Naftolin, F., 1998, Macrophages, estrogen and the microenvironment of breast cancer. J Steroid Biochem Mol Biol, 67:403.

    Article  PubMed  Google Scholar 

  52. Travis, R. C., and Key, T. J., 2003, Oestrogen exposure and breast cancer risk. Breast Cancer Res, 5:239.

    Article  PubMed  Google Scholar 

  53. Kennedy, S., Duffy, M. J., Duggan, C., Barnes, C., Rafferty, R., and Kramer, M. D., 1998, Semi-quantitation of urokinase plasminogen activator and its receptor in breast carcinomas by immunocytochemistry. Br J Cancer, 77:1638.

    PubMed  Google Scholar 

  54. Heppner, K. J., Matrisian, L. M., Jensen, R. A., and Rodgers, W. H., 1996, Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol, 149:273.

    PubMed  Google Scholar 

  55. Pusztai, L., Clover, L. M., Cooper, K., Starkey, P. M., Lewis, C. E., and McGee, J. O., 1994, Expression of tumour necrosis factor alpha and its receptors in carcinoma of the breast. Br J Cancer, 70:289.

    PubMed  Google Scholar 

  56. Miles, D. W., Happerfield, L. C., Naylor, M. S., Bobrow, L. G., Rubens, R. D., and Balkwill, F. R., 1994, Expression of tumour necrosis factor (TNF alpha) and its receptors in benign and malignant breast tissue. Int J Cancer, 56:777.

    PubMed  Google Scholar 

  57. Ueno, T., Toi, M., Saji, H., Muta, M., Bando, H., Kuroi, K., Koike, M., Inadera, H., and Matsushima, K., 2000, Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res, 6:3282.

    PubMed  Google Scholar 

  58. Saji, H., Koike, M., Yamori, T., Saji, S., Seiki, M., Matsushima, K., and Toi, M., 2001, Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma. Cancer, 92:1085.

    Article  PubMed  Google Scholar 

  59. Luboshits, G., Shina, S., Kaplan, O., Engelberg, S., Nass, D., Lifshitz-Mercer, B., Chaitchik, S., Keydar, I., and Ben-Baruch, A., 1999, Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res, 59:4681.

    PubMed  Google Scholar 

  60. Speirs, V., Green, A. R., and White, M. C., 1996, A comparative study of cytokine gene transcripts in normal and malignant breast tissue and primary cell cultures derived from the same tissue samples. Int J Cancer, 66:551.

    Article  Google Scholar 

  61. Sallusto, F., Mackay, C. R., and Lanzavecchia, A., 2000, The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol, 18:593.

    Article  PubMed  Google Scholar 

  62. Kim, C. H., and Broxmeyer, H. E., 1999, Chemokines: signal lamps for trafficking of T and B cells for development and effector function. J Leukoc Biol, 65:6.

    PubMed  Google Scholar 

  63. Locati, M., Otero, K., Schioppa, T., Signorelli, P., Perrier, P., Baviera, S., Sozzani, S., and Mantovani, A., 2002, The chemokine system: tuning and shaping by regulation of receptor expression and coupling in polarized responses. Allergy, 57:972.

    Article  Google Scholar 

  64. Broxmeyer, H. E., and Kim, C. H., 1999, Regulation of hematopoiesis in a sea of chemokine family members with a plethora of redundant activities. Exp Hematol, 27:1113.

    Article  PubMed  Google Scholar 

  65. Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C. L., Ehlert, J. E., Burdick, M. D., and Strieter, R. M., 2000, CXC chemokines in angiogenesis. J Leukoc Biol, 68:1.

    PubMed  Google Scholar 

  66. Murphy, P. M., Baggiolini, M., Charo, I. F., Hebert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., and Power, C. A., 2000, International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev, 52:145.

    PubMed  Google Scholar 

  67. Salcedo, R., and Oppenheim, J. J., 2003, Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses. Microcirculation, 10:359.

    Article  PubMed  Google Scholar 

  68. Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., Barrera, J. L., Mohar, A., Verastegui, E., and Zlotnik, A., 2001, Involvement of chemokine receptors in breast cancer metastasis. Nature, 410:50.

    Article  PubMed  Google Scholar 

  69. Schmid, B. C., Rudas, M., Rezniczek, G. A., Leodolter, S., and Zeillinger, R., 2004, CXCR4 is Expressed in Ductal Carcinoma in situ of the Breast and in Atypical Ductal Hyperplasia. Breast Cancer Res Treat, 84:247.

    Article  Google Scholar 

  70. Kato, M., Kitayama, J., Kazama, S., and Nagawa, H., 2003, Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res, 5:R144.

    Article  PubMed  Google Scholar 

  71. Helbig, G., Christopherson, II, K. W., Bhat-Nakshatri, P., Kumar, S., Kishimoto, H., Miller, K. D., Broxmeyer, H. E., and Nakshatri, H., 2003, NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem, 278:21631.

    Article  PubMed  Google Scholar 

  72. Chen, Y., Stamatoyannopoulos, G., and Song, C. Z., 2003, Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res, 63:4801.

    PubMed  Google Scholar 

  73. Bachelder, R. E., Wendt, M. A., and Mercurio, A. M., 2002, Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res, 62:7203.

    PubMed  Google Scholar 

  74. Fernandis, A. Z., Prasad, A., Band, H., Klosel, R., and Ganju, R. K., 2004, Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene, 23:157.

    Article  PubMed  Google Scholar 

  75. Prasad, A., Fernandis, A. Z., Rao, Y., and Ganju, R. K., 2004, Slit protein-mediated inhibition of CXCR4-induced chemotactic and chemoinvasive signaling pathways in breast cancer cells. J Biol Chem, 279:9115.

    Article  Google Scholar 

  76. Hall, J. M., and Korach, K. S., 2003, Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. Mol Endocrinol, 17:792.

    Article  Google Scholar 

  77. Liotta, L. A., 2001, An attractive force in metastasis. Nature, 410:24.

    Article  PubMed  Google Scholar 

  78. Murphy, P. M., 2001, Chemokines and the molecular basis of cancer metastasis. N Engl J Med, 345:833.

    Article  PubMed  Google Scholar 

  79. Strieter, R. M., 2001, Chemokines: not just leukocyte chemoattractants in the promotion of cancer. Nat Immunol, 2:285.

    Article  PubMed  Google Scholar 

  80. Wolf, M., Clark-Lewis, I., Buri, C., Langen, H., Lis, M., and Mazzucchelli, L., 2003, Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and SLC that are expressed in human breast cancer. Am J Pathol, 162:1183.

    PubMed  Google Scholar 

  81. Braun, S. E., Chen, K., Foster, R. G., Kim, C. H., Hromas, R., Kaplan, M. H., Broxmeyer, H. E., and Cornetta, K., 2000, The CC chemokine CK beta-11/MIP-3 beta/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells. J Immunol, 164:4025.

    PubMed  Google Scholar 

  82. Lee, T. V., Kim, D. K., Peoples, G. E., Castilleja, A., Murray, J. L., Gershenson, D. M., and Ioannides, C. G., 2000, Secretion of CXC chemokine IP-10 by peripheral blood mononuclear cells from healthy donors and breast cancer patients stimulated with HER-2 peptides. J Interferon Cytokine Res, 20:391.

    Article  PubMed  Google Scholar 

  83. Neumark, E., Sagi-Assif, O., Shalmon, B., Ben-Baruch, A., and Witz, I. P., 2003, Progression of mouse mammary tumors: MCP-1-TNFalpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factors. Int J Cancer, 106:879.

    Article  PubMed  Google Scholar 

  84. Aronica, S. M., Fanti, P., Kaminskaya, K., Gibbs, K., Raiber, L., Nazareth, M., Bucelli, R., Mineo, M., Grzybek, K., Kumin, M., Poppenberg, K., Schwach, C., and Janis, K., 2004, Estrogen Disrupts Chemokine-Mediated Chemokine Release from Mammary Cells: Implications for the Interplay between Estrogen and IP-10 in the Regulation of Mammary Tumor Formation. Breast Cancer Res Treat, 84:235.

    Article  Google Scholar 

  85. Dorsey, R., Kundu, N., Yang, Q., Tannenbaum, C. S., Sun, H., Hamilton, T. A., and Fulton, A. M., 2002, Immunotherapy with interleukin-10 depends on the CXC chemokines inducible protein-10 and monokine induced by IFN-gamma. Cancer Res, 62:2606.

    PubMed  Google Scholar 

  86. Pulaski, B. A., Clements, V. K., Pipeling, M. R., and Ostrand-Rosenberg, S., 2000, Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon gamma. Cancer Immunol Immunother, 49:34.

    Article  PubMed  Google Scholar 

  87. Coughlin, C. M., Salhany, K. E., Gee, M. S., LaTemple, D. C., Kotenko, S., Ma, X., Gri, G., Wysocka, M., Kim, J. E., Liu, L., Liao, F., Farber, J. M., Pestka, S., Trinchieri, G., and Lee, W. M.,1998, Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis. Immunity, 9:25.

    Article  PubMed  Google Scholar 

  88. Dias, S., Thomas, H., and Balkwill, F., 1998, Multiple molecular and cellular changes associated with tumour stasis and regression during IL-12 therapy of a murine breast cancer model. Int J Cancer, 75:151.

    Article  PubMed  Google Scholar 

  89. Palmer, K., Hitt, M., Emtage, P. C., Gyorffy, S., and Gauldie, J., 2001, Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity. Gene Ther, 8:282.

    Article  PubMed  Google Scholar 

  90. Luster, A. D., and Leder, P., 1993, IP-10, a-C-X-C-chemokine, elicits a potent thymus-dependent antitumor response in vivo. J Exp Med, 178:1057.

    Article  PubMed  Google Scholar 

  91. Sun, H., Jackson, M. J., Kundu, N., and Fulton, A. M., 1999, Interleukin-10 gene transfer activates interferon-gamma and the interferon-gamma-inducible genes Gbp-1/Mag-1 and Mig-1 in mammary tumors. Int J Cancer, 80:624.

    Article  PubMed  Google Scholar 

  92. Sun, H., Kundu, N., Dorsey, R., Jackson, M. J., and Fulton, A. M., 2001, Expression of the Chemokines IP-10 and Mig in IL-10 Transduced Tumors. J Immunother, 24:138.

    Article  Google Scholar 

  93. Goldberg-Bittman, E., Neumark, E., Sagi-Assif, O., Azenshtein, E., Meshel, T., Witz, I. P., Ben-Baruch, A., 2004, The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines. Immunol Lett, 92:171.

    Article  PubMed  Google Scholar 

  94. Taub, D. D., and Oppenheim, J. J., 1994, Chemokines, inflammation and the immune system. Ther Immunol, 1:229.

    PubMed  Google Scholar 

  95. Rollins, B. J., 1997, Chemokines. Blood, 90:909.

    PubMed  Google Scholar 

  96. Valkovic, T., Lucin, K., Krstulja, M., Dobi-Babic, R., and Jonjic, N., 1998, Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer. Pathol Res Pract, 194:335.

    PubMed  Google Scholar 

  97. Luciani, M. G., Stoppacciaro, A., Peri, G., Mantovani, A., and Ruco, L. P., 1998, The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours. Mol Pathol, 51:273.

    PubMed  Google Scholar 

  98. Inadera, H., Sekiya, T., Yoshimura, T., and Matsushima, K., 2000, Molecular analysis of the inhibition of monocyte chemoattractant protein-1 gene expression by estrogens and xenoestrogens in MCF-7 cells. Endocrinology, 141:50.

    Article  PubMed  Google Scholar 

  99. Kelly, R. W., Carr, G. G., and Riley, S. C., 1997, The inhibition of synthesis of a beta-chemokine, monocyte chemotactic protein-1 (MCP-1) by progesterone. Biochem Biophys Res Commun, 239:557.

    Article  PubMed  Google Scholar 

  100. Azenshtein, E., Luboshits, G., Shina, S., Neumark, E., Shahbazian, D., Weil, M., Wigler, N., Keydar, I., and Ben-Baruch, A., 2002, The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res, 62:1093.

    PubMed  Google Scholar 

  101. Neumark, E., Anavi, R., Witz, I. P., and Ben-Baruch, A., 1999, MCP-1 expression as a potential contributor to the high malignancy phenotype of murine mammary adenocarcinoma cells. Immunol Lett, 68:141.

    Article  Google Scholar 

  102. Neumark, E., Cohn, M. A., Lukanidin, E., Witz, I. P., and Ben-Baruch, A., 2002, Possible co-regulation of genes associated with enhanced progression of mammary adenocarcinomas. Immunol Lett, 82:111.

    Article  PubMed  Google Scholar 

  103. Silzle, T., Kreutz, M,. Dobler, M. A., Brockhoff, G., Knuechel, R., and Kunz-Schughart, L. A., 2003, Tumor-associated fibroblasts recruit blood monocytes into tumor tissue. Eur J Immunol, 33:1311.

    Article  PubMed  Google Scholar 

  104. Salcedo, R., Ponce, M. L., Young, H. A., Wasserman, K., Ward, J. M., Kleinman, H. K., Oppenheim, J. J., and Murphy, W. J., 2000, Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood, 96:34.

    PubMed  Google Scholar 

  105. Vitiello, P. F., Shainheit, M. G., Allison, E. M., Adler, E. P., and Kurt, R. A., 2004, Impact of tumor-derived CCL2 on T cell effector function. Immunol Lett, 91:239.

    Article  PubMed  Google Scholar 

  106. Yamada, M., Kim, S., Egashira, K., Takeya, M., Ikeda, T., Mimura, O., and Iwao, H., 2003, Molecular mechanism and role of endothelial monocyte chemoattractant protein-1 induction by vascular endothelial growth factor. Arterioscler Thromb Vasc Biol, 23:1996.

    Article  PubMed  Google Scholar 

  107. Ohta, M., Kitadai, Y., Tanaka, S., Yoshihara, M., Yasui, W., Mukaida, N., Haruma, K., and Chayama, K., 2002, Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas. Int J Cancer, 102:220.

    Article  PubMed  Google Scholar 

  108. Ohta, M., Kitadai, Y., Tanaka, S., Yoshihara, M., Yasui, W., Mukaida, N., Haruma, K., and Chayama, K., 2003, Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas. Int J Oncol, 22:773.

    PubMed  Google Scholar 

  109. Ambati, B. K., Joussen, A. M., Kuziel, W. A., Adamis, A. P., and Ambati, J., 2003, Inhibition of corneal neovascularization by genetic ablation of CCR2. Cornea, 22:465.

    Article  PubMed  Google Scholar 

  110. Weber, K. S., Nelson, P. J., Grone, H. J., and Weber, C., 1999, Expression of CCR2 by endothelial cells: implications for MCP-1 mediated wound injury repair and In vivo inflammatory activation of endothelium. Arterioscler Thromb Vasc Biol, 19:2085.

    PubMed  Google Scholar 

  111. Robinson, S. C., Scott, K. A., and Balkwill, F. R., 2002, Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha. Eur J Immunol, 32:404.

    Article  PubMed  Google Scholar 

  112. Youngs, S. J., Ali, S. A., Taub, D. D., and Rees, R. C., 1997, Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer, 71:257.

    Article  PubMed  Google Scholar 

  113. Prest, S. J., Rees, R. C., Murdoch, C., Marshall, J. F., Cooper, P. A., Bibby, M., Li, G., and Ali, S. A., 1999, Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials. Clin Exp Metastasis, 17:389.

    Article  PubMed  Google Scholar 

  114. Locati, M., Deuschle, U., Massardi, M. L., Martinez, F. O., Sironi, M., Sozzani, S., Bartfai, T., and Mantovani, A., 2002, Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J Immunol, 168:3557.

    PubMed  Google Scholar 

  115. Adler, E. P., Lemken, C. A., Katchen, N. S., and Kurt, R. A., 2003, A dual role for tumor-derived chemokine RANTES (CCL5). Immunol Lett, 90:187.

    Article  PubMed  Google Scholar 

  116. Robinson, S. C., Scott, K. A., Wilson, J. L., Thompson, R. G., Proudfoot, A. E., and Balkwill, F. R., 2003, A chemokine receptor antagonist inhibits experimental breast tumor growth. Cancer Res, 63:8360.

    PubMed  Google Scholar 

  117. Ali, S., Kaur, J., and Patel, K. D., 2000, Intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and regulated on activation normal T cell expressed and secreted are expressed by human breast carcinoma cells and support eosinophil adhesion and activation. Am J Pathol, 157:313.

    PubMed  Google Scholar 

  118. Niwa, Y., Akamatsu, H., Niwa, H., Sumi, H., Ozaki, Y., and Abe, A., 2001, Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res, 7:285.

    PubMed  Google Scholar 

  119. Mira, E., Lacalle, R. A., Gonzalez, M. A., Gomez-Mouton, C., Abad, J. L., Bernad, A., Martinez, A. C., and Manes, S., 2001, A role for chemokine receptor transactivation in growth factor signaling. EMBO Rep, 2:151.

    Article  PubMed  Google Scholar 

  120. Klier, C. M., Nelson, E. L., Cohen, C. D., Horuk, R., Schlondorff, D., and Nelson, P. J., 2001, Chemokine-Induced secretion of gelatinase B in primary human monocytes. Biol Chem, 382:1405.

    Article  PubMed  Google Scholar 

  121. Manes, S., Mira, E., Colomer, R., Montero, S., Real, L. M., Gomez-Mouton, C., Jimenez-Baranda, S., Garzon, A., Lacalle, R. A., Harshman, K., Ruiz, A., and Martinez, A. C., 2003, CCR5 expression influences the progression of human breast cancer in a p53-dependent manner. J Exp Med, 198:1381.

    Article  PubMed  Google Scholar 

  122. Basolo, F., Fiore, L., Fontanini, G., Conaldi, P. G., Calvo, S., Falcone, V., and Toniolo, A., 1996, Expression of and response to interleukin 6 (IL6) in human mammary tumors. Cancer Res, 56:3118.

    PubMed  Google Scholar 

  123. Pantschenko, A. G., Pushkar, I., Miller, L. J., Wang, Y. P., Anderson, K., Peled, Z., Kurtzman, S. H., and Kreutzer, D. L., 2003, In vitro demonstration of breast cancer tumor cell sub-populations based on interleukin-1/tumor necrosis factor induction of interleukin-8 expression. Oncol Rep, 10:1011.

    PubMed  Google Scholar 

  124. Miller, L. J., Kurtzman, S. H., Wang, Y., Anderson, K. H., Lindquist, R. R., and Kreutzer, D. L., 1998, Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue. Anticancer Res, 18:77.

    PubMed  Google Scholar 

  125. Pantschenko, A. G., Pushkar, I., Anderson, K. H., Wang, Y., Miller, L. J., Kurtzman, S. H., Barrows, G., and Kreutzer, D. L., 2003, The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression. Int J Oncol, 23:269.

    PubMed  Google Scholar 

  126. Green, A. R., Green, V. L., White, M. C., and Speirs, V., 1997, Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast tumours. Int J Cancer, 72:937.

    Article  Google Scholar 

  127. De Larco, J. E., Wuertz, B. R., Rosner, K. A., Erickson, S. A., Gamache, D. E., Manivel, J. C., and Furcht, L. T., 2001, A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells. Am J Pathol, 158:639.

    PubMed  Google Scholar 

  128. Salcedo, R., Martins-Green, M., Gertz, B., Oppenheim, J. J., and Murphy, W. J., 2002, Combined administration of antibodies to human interleukin 8 and epidermal growth factor receptor results in increased antimetastatic effects on human breast carcinoma xenografts. Clin Cancer Res, 8:2655.

    PubMed  Google Scholar 

  129. De Larco, J. E., Wuertz, B. R., Manivel, J. C., and Furcht, L. T., 2001, Progression and enhancement of metastatic potential after exposure of tumor cells to chemotherapeutic agents. Cancer Res, 61:2857.

    PubMed  Google Scholar 

  130. Lev, D. C., Kiriakova, G., and Price, J. E., 2003, Selection of more aggressive variants of the gI101A human breast cancer cell line: a model for analyzing the metastatic phenotype of breast cancer. Clin Exp Metastasis, 20:515.

    Article  PubMed  Google Scholar 

  131. Bendre, M. S., Gaddy-Kurten, D., Mon-Foote, T., Akel, N. S., Skinner, R. A., Nicholas, R. W., and Suva, L. J., 2002, Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. Cancer Res, 62:5571.

    PubMed  Google Scholar 

  132. Lin, Y., Huang, R., Chen, L., Li, S., Shi, Q. Jordan, C., and Huang, R. P., 2004, Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int J Cancer, 109:507.

    Article  PubMed  Google Scholar 

  133. Fujisawa, N., Sakao, Y., Hayashi, S., Hadden, III, W. A., Harmon, C. L., and Miller, E. J., 2000, alpha-Chemokine growth factors for adenocarcinomas; a synthetic peptide inhibitor for alpha-chemokines inhibits the growth of adenocarcinoma cell lines. J Cancer Res Clin Oncol, 126:19.

    PubMed  Google Scholar 

  134. Freund, A., Chauveau, C., Brouillet, J. P., Lucas, A., Lacroix, M., Licznar, A., Vignon, F., and Lazennec, G., 2003, IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells. Oncogene, 22:256.

    Article  PubMed  Google Scholar 

  135. Basolo, F., Conaldi, P. G., Fiore, L., Calvo, S., and Toniolo, A., 1993, Normal breast epithelial cells produce interleukins 6 and 8 together with tumor-necrosis factor: defective IL6 expression in mammary carcinoma. Int J Cancer, 55:926.

    PubMed  Google Scholar 

  136. Palkowetz, K. H., Royer, C. L., Garofalo, R., Rudloff, H. E., Schmalstieg, Jr., F. C., and Goldman, A. S., 1994, Production of interleukin-6 and interleukin-8 by human mammary gland epithelial cells. J Reprod Immunol, 26:57.

    Article  PubMed  Google Scholar 

  137. Maheshwari, A., Christensen, R. D., and Calhoun, D. A., 2003, ELR+ CXC chemokines in human milk. Cytokine, 24:91.

    Article  Google Scholar 

  138. Barber, M. R., Pantschenko, A. G., Hinckley, L. S., and Yang, T. J., 1999, Inducible and constitutive in vitro neutrophil chemokine expression by mammary epithelial and myoepithelial cells. Clin Diagn Lab Immunol, 6:791.

    PubMed  Google Scholar 

  139. Barber, M. R., and Yang, T. J., 1998, Chemotactic activities in nonmastitic and mastitic mammary secretions: presence of interleukin-8 in mastitic but not nonmastitic secretions. Clin Diagn Lab Immunol, 5:82.

    PubMed  Google Scholar 

  140. Nishimura, T., 2003, Expression of potential lymphocyte trafficking mediator molecules in the mammary gland. Vet Res, 34:3.

    Article  PubMed  Google Scholar 

  141. Pusztai, L., Mendoza, T. R., Reuben, J. M., Martinez, M. M., Willey, J. S., Lara, J., Syed, A., Fritsche, H. A., Bruera, E., Booser, D., Valero, V., Arun, B., Ibrahim, N., Rivera, E., Royce, M., Cleeland, C. S., and Hortobagyi, G. N., 2004, Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine, 25:94.

    Article  PubMed  Google Scholar 

  142. Zakrzewska, I., Kozlowski, L., and Wojtukiewicz, M., 2002, Value of interleukin-8 determination in diagnosis of benign and malignant breast tumor. Pol Merkuriusz Lek, 13:302.

    PubMed  Google Scholar 

  143. Kozlowski, L., Zakrzewska, I., Tokajuk, P., and Wojtukiewicz, M. Z., 2003, Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients. Rocz Akad Med Bialymst, 48:82.

    PubMed  Google Scholar 

  144. Yokoe, T., Iino, Y., Takei, H., Horiguchi, J., Koibuchi, Y., Maemura, M., Ohwada, S., and Morishita, Y., 1997, Changes of cytokines and thyroid function in patients with recurrent breast cancer. Anticancer Res, 17:695.

    PubMed  Google Scholar 

  145. Yokoe, T., Iino, Y., and Morishita, Y., 2000, Trends of IL-6 and IL-8 levels in patients with recurrent breast cancer: preliminary report. Breast Cancer, 7:187.

    PubMed  Google Scholar 

  146. Speirs, V., Green, A. R., and Atkin, S. L., 1998, Activity and gene expression of 17beta-hydroxysteroid dehydrogenase type I in primary cultures of epithelial and stromal cells derived from normal and tumourous human breast tissue: the role of IL-8. J Steroid Biochem Mol Biol, 67:267.

    Article  PubMed  Google Scholar 

  147. Schraufstatter, I. U., Trieu, K., Zhao, M., Rose, D. M., Terkeltaub, R. A., and Burger, M., 2003, IL-8-mediated cell migration in endothelial cells depends on cathepsin B activity and transactivation of the epidermal growth factor receptor. J Immunol, 171:6714.

    PubMed  Google Scholar 

  148. Xie, K., 2001, Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev, 12:375.

    Article  PubMed  Google Scholar 

  149. Li, A., Dubey, S., Varney, M. L., and Singh, R. K., 2002, Interleukin-8-induced proliferation, survival, and MMP production in CXCR1 and CXCR2 expressing human umbilical vein endothelial cells. Microvasc Res, 64:476.

    Article  PubMed  Google Scholar 

  150. Heidemann, J., Ogawa, H., Dwinell, M. B., Rafiee, P., Maaser, C., Gockel, H. R., Otterson, M. F., Ota, D. M., Lugering, N., Domschke, W., and Binion, D. G., 2003, Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J Biol Chem, 278:8508.

    Article  Google Scholar 

  151. Addison, C. L., Daniel, T. O., Burdick, M. D., Liu, H., Ehlert, J. E., Xue, Y. Y., Buechi, L., Walz, A., Richmond, A., and Strieter, R. M., 2000, The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J Immunol, 165:5269.

    PubMed  Google Scholar 

  152. Kurtzman, S. H., Anderson, K. H., Wang, Y., Miller, L. J., Renna, M., Stankus, M., Lindquist, R. R., Barrows, G., and Kreutzer, D. L., 1999, Cytokines in human breast cancer: IL-1alpha and IL-1beta expression. Oncol Rep, 6:65.

    PubMed  Google Scholar 

  153. Nozaki, S., Sledge, Jr., G. W., and Nakshatri, H., 2000, Cancer cell-derived interleukin 1alpha contributes to autocrine and paracrine induction of pro-metastatic genes in breast cancer. Biochem Biophys Res Commun, 275:60.

    Article  PubMed  Google Scholar 

  154. Arihiro, K., Oda, H., Kaneko, M., and Inai, K., 2000, Cytokines facilitate chemotactic motility of breast carcinoma cells. Breast Cancer, 7:221.

    PubMed  Google Scholar 

  155. Bendre, M. S., Montague, D. C., Peery, T., Akel, N. S., Gaddy, D., and Suva, L. J., 2003, Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone, 33:28.

    Article  PubMed  Google Scholar 

  156. Bendre, M., Gaddy, D., Nicholas, R. W., and Suva, L. J., 2003, Breast cancer metastasis to bone: it is not all about PTHrP. Clin Orthop, S39.

    Google Scholar 

  157. Rankin, J. A., 2004, Biological mediators of acute inflammation. AACN Clin Issues, 15:3.

    PubMed  Google Scholar 

  158. Palladino, M. A., Bahjat, F. R., Theodorakis, E. A., and Moldawer, L. L., 2003, Anti-TNF-alpha therapies: the next generation. Nat Rev Drug Discov, 2:736.

    Article  PubMed  Google Scholar 

  159. Dinarello, C. A., 2002, The IL-1 family and inflammatory diseases. Clin Exp Rheumatol, 20:S1.

    Google Scholar 

  160. Yudkin, J. S., Kumari, M., Humphries, S. E., and Mohamed-Ali, V., 2000, Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis, 148:209.

    Article  PubMed  Google Scholar 

  161. Kamimura, D., Ishihara, K., and Hirano, T., 2003, IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol, 149:1.

    PubMed  Google Scholar 

  162. Streetz, K. L., Wustefeld, T., Klein, C., Manns, M. P., and Trautwein, C., 2001, Mediators of inflammation and acute phase response in the liver. Cell Mol Biol (Noisy-le-grand), 47:661.

    Google Scholar 

  163. 1994, The cytokine handbook. Thomson A. Academic Press, London.

    Google Scholar 

  164. Robinson, E. K., Sneige, N., and Grimm, E. A., 1998, Correlation of interleukin 6 with interleukin 1alpha in human mammary tumours, but not with oestrogen receptor expression. Cytokine, 10:970.

    Article  PubMed  Google Scholar 

  165. Jin, L., Yuan, R. Q., Fuchs, A., Yao, Y., Joseph, A., Schwall, R., Schnitt, S. J., Guida, A., Hastings, H. M., Andres, J., Turkel, G., Polverini, P. J., Goldberg, I. D., and Rosen, E. M., 1997, Expression of interleukin-1beta in human breast carcinoma. Cancer, 80:421.

    Article  PubMed  Google Scholar 

  166. Miller, L. J., Kurtzman, S. H., Anderson, K., Wang, Y., Stankus, M., Renna, M., Lindquist, R., Barrows, G., and Kreutzer, D. L., 2000, Interleukin-1 family expression in human breast cancer: interleukin-1 receptor antagonist. Cancer Invest, 18:293.

    PubMed  Google Scholar 

  167. Singer, C. F., Kronsteiner, N., Hudelist, G., Marton, E., Walter, I., Kubista, M., Czerwenka, K., Schreiber, M., Seifert, M., and Kubista, E., 2003, Interleukin 1 system and sex steroid receptor expression in human breast cancer: interleukin 1alpha protein secretion is correlated with malignant phenotype. Clin Cancer Res, 9:4877.

    PubMed  Google Scholar 

  168. Bhat-Nakshatri, P., Newton, T. R., Goulet, Jr., R., and Nakshatri, H., 1998, NF-kappaB activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1alpha. Proc Natl Acad Sci USA, 95:6971.

    Article  PubMed  Google Scholar 

  169. Kumar, S., Kishimoto, H., Chua, H. L., Badve, S., Miller, K. D., Bigsby, R. M., and Nakshatri, H., 2003, Interleukin-1 alpha promotes tumor growth and cachexia in MCF-7 xenograft model of breast cancer. Am J Pathol, 163:2531.

    PubMed  Google Scholar 

  170. Voronov, E., Shouval, D. S., Krelin, Y., Cagnano, E., Benharroch, D., Iwakura, Y., Dinarello, C. A., and Apte, R. N., 2003, IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA, 100:2645.

    Article  PubMed  Google Scholar 

  171. Zhang, G. J., and I. Adachi. 1999. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res 19:1427.

    PubMed  Google Scholar 

  172. Sgagias, M. K., Kasid, A., and Danforth, Jr., D. N., 1991, Interleukin-1 alpha and tumor necrosis factor-alpha (TNF alpha) inhibit growth and induce TNF messenger RNA in MCF-7 human breast cancer cells. Mol Endocrinol, 5:1740.

    PubMed  Google Scholar 

  173. Shen, W. H., Zhou, J. H., Broussard, S. R., Freund, G. G., Dantzer, R., and Kelley, K. W., 2002, Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor. Cancer Res, 62:4746.

    PubMed  Google Scholar 

  174. Costantino, A., Vinci, C., Mineo, R., Frasca, F., Pandini, G., Milazzo, G., Vigneri, R., and Belfiore, A., 1996, Interleukin-1 blocks insulin and insulin-like growth factor-stimulated growth in MCF-7 human breast cancer cells by inhibiting receptor tyrosine kinase activity. Endocrinology, 137:4100.

    Article  PubMed  Google Scholar 

  175. Suarez-Cuervo, C., Harris, K. W., Kallman, L., Vaananen, H. K. and Selander, K. S., 2003, Tumor necrosis factor-alpha induces interleukin-6 production via extracellular-regulated kinase 1 activation in breast cancer cells. Breast Cancer Res Treat, 80:71.

    Article  Google Scholar 

  176. Speiser, P., Zeillinger, R., Wiltschke, C., Sedlak, J., and Chorvath, B., 1993, IL-1 alpha induced, TNF alpha mediated HLA class II (DR) antigen up-regulation in a human ductal breast carcinoma cell line ZR-75-1. Neoplasma, 40:137.

    PubMed  Google Scholar 

  177. Verhasselt, B., Van Damme, J., van Larebeke, N., Put, W., Bracke, M., De Potter, C., and Mareel, M., 1992, Interleukin-1 is a motility factor for human breast carcinoma cells in vitro: additive effect with interleukin-6. Eur J Cell Biol, 59:449.

    PubMed  Google Scholar 

  178. Duncan, L. J., Coldham, N. G., and Reed, M. J., 1994, The interaction of cytokines in regulating oestradiol 17 beta-hydroxysteroid dehydrogenase activity in MCF-7 cells. J Steroid Biochem Mol Biol, 49:63.

    Article  PubMed  Google Scholar 

  179. Palmieri, C., Roberts-Clark, D., Assadi-Sabet, A., Coope, R. C., O'Hare, M., Sunters, A., Hanby, A., Slade, M. J., Gomm, J. J., Lam, E. W., and Coombes, R. C., 2003, Fibroblast growth factor 7, secreted by breast fibroblasts, is an interleukin-1beta-induced paracrine growth factor for human breast cells. J Endocrinol, 177:65.

    Article  PubMed  Google Scholar 

  180. Macdiarmid, F., Wang, D., Duncan, L. J., Purohit, A., Ghilchick, M. W., and Reed, M. J., 1994, Stimulation of aromatase activity in breast fibroblasts by tumor necrosis factor alpha. Mol Cell Endocrinol, 106:17.

    Article  PubMed  Google Scholar 

  181. Honma, S., Shimodaira, K., Shimizu, Y., Tsuchiya, N., Saito, H., Yanaihara, T., and Okai, T., 2002, The influence of inflammatory cytokines on estrogen production and cell proliferation in human breast cancer cells. Endocr J, 49:371.

    PubMed  Google Scholar 

  182. de Jong, P. C., Blankenstein, M. A., van de Ven, J., Nortier, J. W., Blijham, G. H., and Thijssen, J. H., 2001, Importance of local aromatase activity in hormone-dependent breast cancer: a review. Breast, 10:91.

    Article  PubMed  Google Scholar 

  183. Simpson, E. R., 2000, Biology of aromatase in the mammary gland. J Mammary Gland Biol Neoplasia, 5:251.

    Article  PubMed  Google Scholar 

  184. Brueggemeier, R. W., J. A. Richards, and T. A. Petrel. 2003. Aromatase and cyclooxygenases: enzymes in breast cancer. J Steroid Biochem Mol Biol 86:501.

    Article  PubMed  Google Scholar 

  185. Cameron, D. J., and O'Brien, P., 1982, Relationship of the suppression of macrophage mediated tumor cytotoxicity in conjunction with secretion of prostaglandin from the macrophages of breast cancer patients. Int J Immunopharmacol, 4:445.

    Article  PubMed  Google Scholar 

  186. Sombroek, C. C., Stam, A. G., Masterson, A. J., Lougheed, S. M., Schakel, M. J., Meijer, C. J., Pinedo, H. M., van den Eertwegh, A. J., Scheper, R. J., and de Gruijl, T. D., 2002, Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation. J Immunol, 168:4333.

    PubMed  Google Scholar 

  187. Pockaj, B. A., Basu, G. D., Pathangey, L. B., Gray, R. J., Hernandez, J. L., Gendler, S. J., and Mukherjee, P., 2004, Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer. Ann Surg Oncol, 11:328.

    Article  PubMed  Google Scholar 

  188. Purohit, A., Singh, A., Ghilchik, M. W., and Reed, M. J., 1999, Inhibition of tumor necrosis factor alpha-stimulated aromatase activity by microtubule-stabilizing agents, paclitaxel and 2-methoxyestradiol. Biochem Biophys Res Commun, 261:214.

    Article  PubMed  Google Scholar 

  189. Schrey, M. P., and Patel, K. V., 1995, Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators. Br J Cancer, 72:1412.

    PubMed  Google Scholar 

  190. Szlosarek, P. W., and Balkwill, F. R., 2003, Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. Lancet Oncol, 4:565.

    Article  PubMed  Google Scholar 

  191. Carpenter, P. M., Gatanaga, T., Nguyen, H. P., and Hiserodt, J. C., 1997, Lymphocyte and monocyte-induced motility of MCF-7 cells by tumor necrosis factor-alpha. Int J Cancer, 71:64.

    Article  PubMed  Google Scholar 

  192. Leek, R. D., Landers, R., Fox, S. B., Ng, F., Harris, A. L., and Lewis, C. E., 1998, Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. Br J Cancer, 77:2246.

    PubMed  Google Scholar 

  193. Krajcik, R. A., Massardo, S., and Orentreich, N., 2003, No association between serum levels of tumor necrosis factor-alpha (TNF-alpha) or the soluble receptors sTNFR1 and sTNFR2 and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 12:945.

    PubMed  Google Scholar 

  194. Sabel, M. S., Skitzki, J., Stoolman, L., Egilmez, N. K., Mathiowitz, E., Bailey, N., Chang, W. J., and Chang, A. E., 2004, Intratumoral IL-12 and TNF-alpha-loaded microspheres lead to regression of breast cancer and systemic antitumor immunity. Ann Surg Oncol, 11:147.

    Article  PubMed  Google Scholar 

  195. de Kossodo, S., Moore, R., Gschmeissner, S., East, N., Upton, C., and Balkwill, F. R., 1995, Changes in endogenous cytokines, adhesion molecules and platelets during cytokine-induced tumour necrosis. Br J Cancer, 72:1165.

    PubMed  Google Scholar 

  196. Budinsky, A. C., Brodowicz, T., Wiltschke, C., Czerwenka, K., Michl, I., Krainer, M., and Zielinski, C. C., 1997, Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast-cancer cells in vitro. Int J Cancer, 71:1086.

    Article  PubMed  Google Scholar 

  197. Basu, A., Mohanty, S., and Sun, B., 2001, Differential sensitivity of breast cancer cells to tumor necrosis factor-alpha: involvement of protein kinase C. Biochem Biophys Res Commun, 280:883.

    Article  PubMed  Google Scholar 

  198. Weitsman, G. E., Ravid, A., Liberman, U. A., and Koren, R., 2003, Vitamin D enhances caspase-dependent and-independent TNFalpha-induced breast cancer cell death: The role of reactive oxygen species and mitochondria. Int J Cancer, 106:178.

    Article  PubMed  Google Scholar 

  199. Diarra-Mehrpour, M., Arrabal, S., Jalil, A., Pinson, X., Gaudin, C., Pietu, G., Pitaval, A., Ripoche, H., Eloit, M., Dormont, D., and Chouaib, S., 2004, Prion protein prevents human breast carcinoma cell line from tumor necrosis factor alpha-induced cell death. Cancer Res, 64:719.

    Article  PubMed  Google Scholar 

  200. Basu, A., 1998, The involvement of novel protein kinase C isozymes in influencing sensitivity of breast cancer MCF-7 cells to tumor necrosis factor-alpha. Mol Pharmacol, 53:105.

    PubMed  Google Scholar 

  201. Cai, Z., Capoulade, C., Moyret-Lalle, C., Amor-Gueret, M., Feunteun, J., Larsen, A. K., Paillerets, B. B., and Chouaib, S., 1997, Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function. Oncogene, 15:2817.

    Article  Google Scholar 

  202. Burow, M. E., Weldon, C. B., Tang, Y., McLachlan, J. A., and Beckman, B. S., 2001, Oestrogen-mediated suppression of tumour necrosis factor alpha-induced apoptosis in MCF-7 cells: subversion of Bcl-2 by anti-oestrogens. J Steroid Biochem Mol Biol, 78:409.

    Article  PubMed  Google Scholar 

  203. Egeblad, M., and Jaattela, M., 2000, Cell death induced by TNF or serum starvation is independent of ErbB receptor signaling in MCF-7 breast carcinoma cells. Int J Cancer, 86:617.

    Article  PubMed  Google Scholar 

  204. Hoffmann, M., Schmidt, M., and Wels, W., 1998, Activation of EGF receptor family members suppresses the cytotoxic effects of tumor necrosis factor-alpha. Cancer Immunol Immunother, 47:167.

    Article  PubMed  Google Scholar 

  205. Burow, M. E., Weldon, C. B., Tang, Y., Navar, G. L., Krajewski, S., Reed, J. C., Hammond, T. G., Clejan, S., and Beckman, B. S., 1998, Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Res, 58:4940.

    PubMed  Google Scholar 

  206. Rozen, F., Zhang, J., and Pollak, M., 1998, Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breastcancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation. Int J Oncol, 13:865.

    PubMed  Google Scholar 

  207. Amin, F., Bowen, I. D., Szegedi, Z., Mihalik, R., and Szende, B., 2000, Apoptotic and non-apoptotic modes of programmed cell death in MCF-7 human breast carcinoma cells. Cell Biol Int, 24:253.

    Article  PubMed  Google Scholar 

  208. Burow, M. E., Tang, Y., Collins-Burow, B. M., Krajewski, S., Reed, J. C., McLachlan, J. A., and Beckman, B. S., 1999, Effects of environmental estrogens on tumor necrosis factor alpha-mediated apoptosis in MCF-7 cells. Carcinogenesis, 20:2057.

    Article  PubMed  Google Scholar 

  209. Sheen-Chen, S. M., Chen, W. J., Eng, H. L., and Chou, F. F., 1997, Serum concentration of tumor necrosis factor in patients with breast cancer. Breast Cancer Res Treat, 43:211.

    Article  PubMed  Google Scholar 

  210. Varela, L. M., Stangle-Castor, N. C., Shoemaker, S. F., Shea-Eaton, W. K., and Ip, M. M., 2001, TNFalpha induces NFkappaB/p50 in association with the growth and morphogenesis of normal and transformed rat mammary epithelial cells. J Cell Physiol, 188:120.

    Article  PubMed  Google Scholar 

  211. Purohit, A., Newman, S. P., and Reed, M. J., 2002, The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer. Breast Cancer Res, 4:65.

    Article  PubMed  Google Scholar 

  212. Vaday, G. G., Hershkoviz, R., Rahat, M. A., Lahat, N., Cahalon, L., and Lider, O., 2000, Fibronectin-bound TNF-alpha stimulates monocyte matrix metalloproteinase-9 expression and regulates chemotaxis. J Leukoc Biol, 68:737.

    PubMed  Google Scholar 

  213. Chiu, J. J., Sgagias, M. K., and Cowan, K. H., 1996, Interleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines. Clin Cancer Res, 2:215.

    PubMed  Google Scholar 

  214. Fontanini, G., Campani, D., Roncella, M., Cecchetti, D., Calvo, S., Toniolo, A., and Basolo, F., 1999, Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma. Br J Cancer 80:579.

    Article  Google Scholar 

  215. Karczewska, A., Nawrocki, S., Breborowicz, D. Filas, V., and Mackiewicz, A., 2000, Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma. Cancer, 88:2061.

    Article  PubMed  Google Scholar 

  216. Asgeirsson, K. S., Olafsdottir, K., Jonasson, J. G., and Ogmundsdottir, H. M., 1998, The effects of IL-6 on cell adhesion and e-cadherin expression in breast cancer. Cytokine, 10:720.

    Article  PubMed  Google Scholar 

  217. Krueger, J., Ray, A., Tamm, I., and Sehgal, P. B., 1991, Expression and function of interleukin-6 in epithelial cells. J Cell Biochem, 45:327.

    Article  PubMed  Google Scholar 

  218. Sehgal, P. B., and Tamm, I., 1991, Interleukin-6 enhances motility of breast carcinoma cells. Exs, 59:178.

    PubMed  Google Scholar 

  219. Salgado, R., Junius, S., Benoy, I., Van Dam, P., Vermeulen, P., Van Marck, E., Huget, P., and Dirix, L. Y., 2003, Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int J Cancer, 103:642.

    Article  PubMed  Google Scholar 

  220. Bachelot, T., Ray-Coquard, I., Menetrier-Caux, C., Rastkha, M., Duc, A., and Blay, J. Y., 2003, Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br J Cancer, 88:1721.

    Article  PubMed  Google Scholar 

  221. Benoy, I., Salgado, R., Colpaert, C., Weytjens, R., Vermeulen, P. B., and Dirix, L. Y., 2002, Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients. Clin Breast Cancer, 2:311.

    PubMed  Google Scholar 

  222. Speirs, V., Walton, D. S., Hall, M. C., and Atkin, S. L., 1999, In vivo and in vitro expression of steroid-converting enzymes in human breast tumours: associations with interleukin-6. Br J Cancer, 81:690.

    Article  PubMed  Google Scholar 

  223. Jiang, X. P., Yang, D. C., Elliott, R. L., and Head, J. F., 2000, Reduction in serum IL-6 after vacination of breast cancer patients with tumour-associated antigens is related to estrogen receptor status. Cytokine, 12:458.

    Article  PubMed  Google Scholar 

  224. DeMichele, A., Martin, A. M., Mick, R., Gor, P., Wray, L., Klein-Cabral, M., Athanasiadis, G., Colligan, T., Stadtmauer, E., and Weber, B., 2003, Interleukin-6 −174G—>C polymorphism is associated with improved outcome in high-risk breast cancer. Cancer Res, 63:8051.

    PubMed  Google Scholar 

  225. Iacopetta, B., Grieu, F., and Joseph, D., 2004, The-174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype. Br J Cancer, 90:419.

    Article  PubMed  Google Scholar 

  226. Conze, D., Weiss, L., Regen, P. S., Bhushan, A., Weaver, D., Johnson, P., and Rincon, M., 2001, Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells. Cancer Res, 61:8851.

    PubMed  Google Scholar 

  227. Di Carlo, E., Modesti, A., Castrilli, G., Landuzzi, L., Allione, A., de Giovanni, C., Musso, T., and Musiani, P., 1997, Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential. J Pathol, 182:76.

    Article  PubMed  Google Scholar 

  228. Purohit, A., Singh, A., Ghilchik, M. W., Serlupi-Crescenzi, O., and Reed, M. J., 2003, Inhibition of IL-6+IL-6 soluble receptor-stimulated aromatase activity by the IL-6 antagonist, Sant 7, in breast tissue-derived fibroblasts. Br J Cancer, 88:630.

    Article  PubMed  Google Scholar 

  229. Utsumi, K., Takai, Y., Tada, T., Ohzeki, S., Fujiwara, H., and Hamaoka, T., 1990, Enhanced production of IL-6 in tumor-bearing mice and determination of cells responsible for its augmented production. J Immunol, 145:397.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, Israel

    A. Ben-Baruch

Authors
  1. A. Ben-Baruch
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Washington State University, Pullman, WA, USA

    Gary G. Meadows

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer

About this chapter

Cite this chapter

Ben-Baruch, A. (2005). Breast Cancer Progression: A “Vicious Cycle” of Pro-Malignancy Activities is Mediated by Inflammatory Cells, Chemokines and Cytokines. In: Meadows, G.G. (eds) Integration/Interaction of Oncologic Growth. Cancer Growth and Progression, vol 15. Springer, Dordrecht. https://doi.org/10.1007/1-4020-3414-8_11

Download citation

Publish with us

Policies and ethics

Search

Navigation